Virtual screening of natural compounds as inhibitors of EGFR 696-1022 T790M associated with non-small cell lung cancer

Non-small cell lung cancer (NSCLC) is the most dominating and lethal type of lung cancer triggering more than 1.3 million deaths per year. The most effective line of treatment against NSCLC is to target epidermal growth factor receptor (EGFR) activating mutation. The present study aims to identify t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nand, Mahesha, Maiti, Priyanka, Pant, Ragini, Kumari, Madhulata, Chandra, Subhash, Pande, Veena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2016
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320927/
https://www.ncbi.nlm.nih.gov/pubmed/28293073
http://dx.doi.org/10.6026/97320630012311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320927/
https://www.ncbi.nlm.nih.gov/pubmed/28293073
http://dx.doi.org/10.6026/97320630012311

Ejemplares similares